2017
DOI: 10.5582/irdr.2017.01063
|View full text |Cite
|
Sign up to set email alerts
|

Disseminated mucormycosis: A sinister cause of neutropenic fever syndrome

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
5
0
2

Year Published

2018
2018
2024
2024

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 9 publications
(7 citation statements)
references
References 16 publications
0
5
0
2
Order By: Relevance
“…Disseminated mucormycosis is the least common and the worst prognosis type, and it mostly starts with lesions in the lungs and then disseminates to other sites. Cardiac dissemination of pulmonary mucormycosis, like in our case, is unusual and often diagnosed postmortem; an antemortem diagnosis is very rare and only four such cases have been reported till 2017 [3-6]. We present the case of an immunocompromised patient with cardiac involvement as part of disseminated mucormycosis syndrome.…”
Section: Introductionmentioning
confidence: 71%
“…Disseminated mucormycosis is the least common and the worst prognosis type, and it mostly starts with lesions in the lungs and then disseminates to other sites. Cardiac dissemination of pulmonary mucormycosis, like in our case, is unusual and often diagnosed postmortem; an antemortem diagnosis is very rare and only four such cases have been reported till 2017 [3-6]. We present the case of an immunocompromised patient with cardiac involvement as part of disseminated mucormycosis syndrome.…”
Section: Introductionmentioning
confidence: 71%
“…13,14 In this case, we observed a rare form of disseminated mucormycosis from a person living with HIV. Whilst clinical diversity of mucormycosis makes it difficult to diagnose, 15 this case is a lesson that a high index of suspicion in the correct clinical setting is important to decrease morbidity and mortality associated with this infection. Mucormycosis should also enter into the list of differential diagnosis in HIV-infected patients.…”
Section: Discussionmentioning
confidence: 97%
“…Bio-Rad Laboratories, 2019 , John, 0000 , Morris et al, 2012 , Ndhlovu et al, 2012 , Nicolas et al, 2020 , Nomani et al, 2021 , Perez et al, 2005 , Philippe et al, 2003 , Randeria et al, 2019 , Richman, 1983 , Sato et al, 2003 , Schmidt et al, 2013 , Schmidt et al, 2017 , Schofield et al, 2017 , Sepehri et al, 2016 , Singh et al, 2022 , Slifkin and Cumbie, 1992 , Spellberg et al, 2005 , Tansir et al, 2017 , Van Den Eeckhout et al, 2020 , Vigon et al, 2021 , Webb et al, 2020 , WHO, 2022 , Wurster et al, 2017 .…”
Section: Uncited Referencesmentioning
confidence: 99%